Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which pain relief helps you recover faster after hip surgery?

NCT ID NCT07803133

Symptom relief Sponsor: Erzincan Binali Yildirim Universitesi Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 03, 2026 · Last updated Sep 10, 2026 · Updated 3 times

Summary

This trial tests two ways to manage pain after hip replacement surgery: a nerve block near the hip joint (PENG block) and a small dose of morphine given with spinal anesthesia. Adults scheduled for elective hip replacement will be randomly assigned to one of the two methods. Researchers will measure quality of recovery 24 hours after surgery using a questionnaire, and also track pain, opioid use, movement, and side effects. The goal is to see if one approach leads to a smoother, more comfortable recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Pericapsular nerve group (PENG) block with bupivacaine, compared to intrathecal morphine
What this could lead to
If one method works better, it could point to a standard way to manage pain after hip replacement, helping people recover faster and with fewer side effects.
What could go wrong
This is a single trial with 90 participants, so results may not apply to everyone. Both methods carry risks like allergic reactions or nerve damage, and the trial has not yet reported outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-85 years * American Society of Anesthesiologists (ASA) physical status I-III * Scheduled for elective primary unilateral total hip arthroplasty * Planned spinal anesthesia * Ability to understand and complete the Quality of Recovery-15 (QoR-15) questionnaire and Numeric Rating Scale (NRS) pain assessments * Provision of written informed consent Exclusion Criteria: * Contraindication to spinal anesthesia or PENG block * Known allergy or hypersensitivity to local anesthetics or morphine * Coagulation disorder * Therapeutic anticoagulant use * Infection at the planned injection site * Chronic opioid use * History of substance abuse * Severe cognitive impairment that prevents reliable completion of study assessments * Advanced hepatic or renal failure * ASA physical status IV or higher * Revision total hip arthroplasty * Surgery for pathological fracture or tumor * Pregnancy * Requirement for general anesthesia * Refusal to participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postoperative pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Postoperative pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Erzincan Binali Yildirim University Mengucek Gazi Training and Research Hospital

    Erzincan, Erzincan, 06170, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.